Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Desmond Tutu Health Foundation, Cape Town, South Africa.
PLoS One. 2024 Nov 25;19(11):e0309905. doi: 10.1371/journal.pone.0309905. eCollection 2024.
Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings.
Building on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa.
These trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
提高艾滋病毒感染者(PLHIV)中的艾滋病毒检测和治疗覆盖率对于实现全球艾滋病毒疫情控制至关重要。然而,与女性相比,感染艾滋病毒的顺性别异性恋男性不太可能了解自己的艾滋病毒状况,启动抗逆转录病毒治疗(ART)并实现病毒抑制。在南非尤其如此,男性死于艾滋病相关疾病的风险也更高。虽然在西方和高收入国家,PLHIV 对“治疗即预防”或“检测不到即无法传播”(U = U)概念的了解越来越多,但撒哈拉以南非洲地区 U = U 信息的传播和普及仍然有限,而且很少有研究评估可及且相关的 U = U 信息对 ART 启动和坚持的影响。为了解决这些差距,需要对包含 U = U 信息的干预措施进行严格评估,特别是在高流行地区的男性中。
基于我们之前使用行为经济学见解和以人为中心的设计为男性开发的 U = U 信息,我们将进行两项连续的混合 1 型有效性-实施试验,以评估 U = U 信息对男性接受社区为基础的艾滋病毒检测和开始接受抗逆转录病毒治疗(试验 1)以及保留在护理中并实现病毒抑制(试验 2)的影响。对于试验 1,将实施一项基于集群的随机试验,将艾滋病毒检测服务日(每个检测点每天一次)随机分配给 U = U 或标准护理(SoC)信息,邀请男性进行艾滋病毒检测。对于试验 2,将实施一项个体水平的随机对照试验,在六家政府诊所开始接受抗逆转录病毒治疗的男性将被随机分配接受 U = U 咨询或 SoC 治疗依从性信息。我们将采用多方法评估为 U = U 信息干预措施的未来实施提供信息。该研究将在南非东开普省布法罗城市都会区和西开普省开普敦都会区进行。
这些试验是首次严格评估 U = U 信息对非洲男性接受艾滋病毒检测、开始接受抗逆转录病毒治疗和实现病毒抑制的影响。如果有效,这些信息干预措施可以为全球艾滋病毒检测、治疗和坚持咨询准则和实践提供参考。